Physiologic rationale for calcium antagonist therapy in essential hypertension

Area of Science:

• Cardiology
• Internal Medicine
• Hypertension Research

Background:

• Hypertension is often viewed as a disease, but it is a vital sign indicating an underlying condition.
• Essential hypertension, where causes are unknown, constitutes about 90% of cases.
• Treating only elevated blood pressure does not fully mitigate cardiovascular risks associated with the underlying disease.

Purpose of the Study:

• To highlight that hypertension is a sign of a disease, not the disease itself.
• To emphasize the multisystemic nature of hypertensive cardiovascular disease, including left ventricular hypertrophy and insulin resistance.
• To underscore the pathophysiologic and clinical heterogeneity of hypertension, necessitating individualized treatment approaches.

Main Methods:

• Review of clinical trial data over two decades.
• Analysis of peripheral manifestations of hypertension beyond blood pressure.
• Consideration of underlying pathophysiologic factors contributing to hypertension and its related conditions.

Main Results:

• Elevated blood pressure is a sign, not the disease; treating only this sign partially addresses cardiovascular risk.
• Hypertension involves multisystemic manifestations like left ventricular hypertrophy and insulin resistance, which can progress independently.
• Clinical trials indicate that hypertension is heterogeneous, with varying responses to treatment based on individual patient factors, such as salt sensitivity.

Conclusions:

• Effective management of hypertensive cardiovascular disease requires addressing the underlying disease process, not just blood pressure levels.
• Recognizing hypertension as a sign and understanding its multisystemic involvement is crucial for comprehensive patient care.
• Individualized treatment strategies are essential due to the significant pathophysiologic and clinical heterogeneity of hypertension.